Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL)
Francesco Gelsomino,Marcello Tiseo,Fausto Barbieri,Ferdinando Riccardi,Luigi Cavanna,Antonio Frassoldati,Angelo Delmonte,Lucia Longo,Claudio Dazzi,Saverio Cinieri,Ida Colantonio,Francesca Sperandi,Giuseppe Lamberti,Stefano Brocchi,Lorenzo Tofani,Luca Boni,Andrea Ardizzoni British Journal of Cancer（2021）
AI 理解论文
溯源树
样例
